Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
American Journal of Cardiovascular Disease|November 23, 2012
Valvular heart disease and 3-dimensional echocardiography: ready for prime-time?Luis M Moura, Leopoldo Perez de IslaExpert Review of Cardiovascular Therapy|April 23, 2020
Bench to bedside defining calcific aortic valve disease: osteocardiologyNalini M Rajamannan, Luis M Moura, Patricia BestExpert Review of Cardiovascular Therapy|March 24, 2015
SALTIRE-RAAVE: targeting calcific aortic valve disease LDL-density-radius theoryNalini M Rajamannan, Anders M Greve, Luis M Moura, et al.Current Opinion in Cardiology|October 9, 2007
New understanding about calcific aortic stenosis and opportunities for pharmacologic interventionLuis M Moura, Kameswari Maganti, Jyothy J Puthumana, et al.Expert Review of Cardiovascular Therapy|August 1, 2008
New cardiovascular biomarkers: clinical implications in patients with valvular heart diseaseLuis M Moura, Francisco Rocha-Gonçalves, José L Zamorano, et al.The Journal of Heart Valve Disease|September 8, 2012
Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosisLuis M Moura, Sandra F Ramos, Steen D Kristensen, et al.Journal of the American College of Cardiology|February 6, 2007
Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosisLuis M Moura, Sandra F Ramos, José L Zamorano, et al.American Journal of Cardiovascular Disease|June 22, 2012
Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosisLuis M Moura, Susana Faria, Miguel Brito, et al.Circulation|May 5, 2010
Effect of hydroxymethylglutaryl coenzyme-a reductase inhibitors on the long-term progression of rheumatic mitral valve diseaseFrancesco Antonini-Canterin, Luis M Moura, Roxana Enache, et al.Pageof 1